BYSL and central nervous system cancer: The BYSL mRNA levels showed a significant increase in grade II (n = 24, P = 0.043), grade III (n = 85, P < 0.001) and grade IV (n = 159, P < 0.001) in glioma tissues when compared to those in nontumor tissues (Figure 1A).